Original Research
Accepted on 18 Feb 2025
Camrelizumab-based therapies for the treatment of advanced lung cancer: a prospective, open-label, multicenter, observational, real-world study
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 18 Feb 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 18 Feb 2025
in Cancer Imaging and Image-directed Interventions
Original Research
Accepted on 18 Feb 2025
in Functional Plant Ecology
Original Research
Accepted on 18 Feb 2025
in Geohazards and Georisks
Correction
Accepted on 18 Feb 2025
in Food Characterization
Original Research
Accepted on 18 Feb 2025
in Crop and Product Physiology
Original Research
Accepted on 18 Feb 2025
in Virtual Reality and Human Behaviour
Editorial
Accepted on 18 Feb 2025
in Gynecological Oncology
Original Research
Accepted on 18 Feb 2025
in Sustainable Organizations
Original Research
Accepted on 18 Feb 2025
in Landscape and Geological Processes
Original Research
Accepted on 18 Feb 2025
in Neurorehabilitation
Original Research
Accepted on 18 Feb 2025
in Nutrition and Food Science Technology
Original Research
Accepted on 18 Feb 2025
in Environmental Health and Exposome
Editorial
Accepted on 18 Feb 2025
in Fungal Pathogenesis
Brief Research Report
Accepted on 18 Feb 2025
in Comparative Governance
Review
Accepted on 18 Feb 2025
in Obstetrics and Gynecology